SCHEMBL1742507

SCHEMBL1742507

NC(=S)CCC(Cc1ccc(C(F)(F)F)nc1)NC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
KCNQ4 P56696 1/20 0.36
KCNQ5 Q9NR82 1/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
CYP3A4 P08684 2/20 0.35
CYP3A5 P20815 1/20 0.35
PPARD Q03181 1/20 0.35
PLAAT3 P53816 1/20 0.35
PLAAT5 Q96KN8 1/20 0.35
PLAAT2 Q9NWW9 1/20 0.35
PLAAT4 Q9UL19 1/20 0.35
MME P08473 1/20 0.34
KDM1A O60341 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1744297 0.91 KCNQ3 (0.37) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL3636064 0.86 MME (0.36) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL13285668 0.85 ATM (0.40) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL1744255 0.82 FFAR2 (0.42) MME
SCHEMBL1743303 0.82 TRPV3 (0.41) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL3644221 0.81 TRPV3 (0.42) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL1519770 0.81 CYP2C9 (0.36) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL1742124 0.76 ATM (0.41) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL1742125 0.76 ATM (0.41) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9
SCHEMBL3668779 0.74 CYP2C9 (0.36) KCNQ3KCNQ2KCNQ4KCNQ5CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 KCNQ3 1903/4885KCNQ2 1802/4885KCNQ4 2195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.